Maxwell Biosciences, Inc

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Maxwell is an early stage biotech company in lead optimization developing a broad spectrum virucide. Mimicking Human Cathelicidin Antimicrobial Peptide - humanity’s only cathelicidin antimicrobial peptide - Maxwell Biosciences is developing a completely new drug class proven to irreversibly destroy pandemic viruses like SARS-CoV-2, Hepatitis B, and Herpes Simplex Virus 1.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Texas
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
HSV-1
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
MaxWell Biosciences